FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147963921> ?p ?o ?g. }

• W3147963921 endingPage "371" @default.
• W3147963921 startingPage "371" @default.
• W3147963921 abstract "Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype because of its high metastatic potential. Immune evasion due to aberrant expression of programmed cell death ligand 1 (PD-L1) has also been reported recently in metastatic TNBC. However, the mechanism underlying metastatic progression and PD-L1 upregulation in TNBC is still largely unknown. Here, we found that guanylate binding protein 5 (GBP5) is expressed in higher levels in TNBC tissues than in non-TNBC and normal mammary tissues and serves as a poorer prognostic marker in breast cancer patients. Transwell cultivation indicated that GBP5 expression is causally related to cellular migration ability in the detected TNBC cell lines. Moreover, the computational simulation of the gene set enrichment analysis (GSEA) program against the GBP5 signature generated from its coexpression with other somatic genes in TNBC revealed that GBP5 upregulation may be associated with the activation of interferon gamma (IFN-γ)-responsive and NF-κB-related signaling cascades. In addition, we found that the coexpression of GBP5 with PD-L1 was significantly positive correlation in TNBC tissues. Robustly, our data showed that GBP5 knockdown in TNBC cells harboring a higher GBP5 level dramatically suppresses the number of migrated cells, the activity of IFN-γ/STAT1 and TNF-α/NF-κB signaling axes, and the expression of PD-L1. Importantly, the signature combining a higher GBP5 and PD-L1 level predicted the shortest time interval of brain metastasis in breast cancer patients. These findings not only uncover the oncogenic function of GBP5 but also provide a new strategy to combat metastatic/immunosuppressive TNBC by targeting GBP5 activity." @default.
• W3147963921 created "2021-04-13" @default.
• W3147963921 creator A5003495274 @default.
• W3147963921 creator A5007831390 @default.
• W3147963921 creator A5032131879 @default.
• W3147963921 creator A5046365133 @default.
• W3147963921 creator A5051199484 @default.
• W3147963921 creator A5069581727 @default.
• W3147963921 date "2021-04-01" @default.
• W3147963921 modified "2023-10-16" @default.
• W3147963921 title "GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer" @default.
• W3147963921 cites W1497553226 @default.
• W3147963921 cites W1582285271 @default.
• W3147963921 cites W1972097448 @default.
• W3147963921 cites W1999558098 @default.
• W3147963921 cites W2024644688 @default.
• W3147963921 cites W2035570331 @default.
• W3147963921 cites W2037578345 @default.
• W3147963921 cites W2064456932 @default.
• W3147963921 cites W2097255042 @default.
• W3147963921 cites W2100413206 @default.
• W3147963921 cites W2106457415 @default.
• W3147963921 cites W2113664558 @default.
• W3147963921 cites W2141270539 @default.
• W3147963921 cites W2418955475 @default.
• W3147963921 cites W2547855452 @default.
• W3147963921 cites W2550291749 @default.
• W3147963921 cites W2620374892 @default.
• W3147963921 cites W2767509615 @default.
• W3147963921 cites W2784044161 @default.
• W3147963921 cites W2785416267 @default.
• W3147963921 cites W2791090958 @default.
• W3147963921 cites W2889504847 @default.
• W3147963921 cites W2963119757 @default.
• W3147963921 cites W2965576600 @default.
• W3147963921 cites W2976001270 @default.
• W3147963921 cites W2981429234 @default.
• W3147963921 cites W3000523485 @default.
• W3147963921 cites W3036095870 @default.
• W3147963921 cites W3046421105 @default.
• W3147963921 cites W3048527268 @default.
• W3147963921 cites W3048627912 @default.
• W3147963921 cites W3095107406 @default.
• W3147963921 cites W3110972914 @default.
• W3147963921 cites W3098862677 @default.
• W3147963921 doi "https://doi.org/10.3390/biomedicines9040371" @default.
• W3147963921 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8066311" @default.
• W3147963921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33916322" @default.
• W3147963921 hasPublicationYear "2021" @default.
• W3147963921 type Work @default.
• W3147963921 sameAs 3147963921 @default.
• W3147963921 citedByCount "13" @default.
• W3147963921 countsByYear W31479639212022 @default.
• W3147963921 countsByYear W31479639212023 @default.
• W3147963921 crossrefType "journal-article" @default.
• W3147963921 hasAuthorship W3147963921A5003495274 @default.
• W3147963921 hasAuthorship W3147963921A5007831390 @default.
• W3147963921 hasAuthorship W3147963921A5032131879 @default.
• W3147963921 hasAuthorship W3147963921A5046365133 @default.
• W3147963921 hasAuthorship W3147963921A5051199484 @default.
• W3147963921 hasAuthorship W3147963921A5069581727 @default.
• W3147963921 hasBestOaLocation W31479639211 @default.
• W3147963921 hasConcept C104317684 @default.
• W3147963921 hasConcept C121608353 @default.
• W3147963921 hasConcept C126322002 @default.
• W3147963921 hasConcept C127561419 @default.
• W3147963921 hasConcept C173396325 @default.
• W3147963921 hasConcept C2779013556 @default.
• W3147963921 hasConcept C2780110267 @default.
• W3147963921 hasConcept C502942594 @default.
• W3147963921 hasConcept C530470458 @default.
• W3147963921 hasConcept C54355233 @default.
• W3147963921 hasConcept C55493867 @default.
• W3147963921 hasConcept C71924100 @default.
• W3147963921 hasConcept C81885089 @default.
• W3147963921 hasConcept C86803240 @default.
• W3147963921 hasConceptScore W3147963921C104317684 @default.
• W3147963921 hasConceptScore W3147963921C121608353 @default.
• W3147963921 hasConceptScore W3147963921C126322002 @default.
• W3147963921 hasConceptScore W3147963921C127561419 @default.
• W3147963921 hasConceptScore W3147963921C173396325 @default.
• W3147963921 hasConceptScore W3147963921C2779013556 @default.
• W3147963921 hasConceptScore W3147963921C2780110267 @default.
• W3147963921 hasConceptScore W3147963921C502942594 @default.
• W3147963921 hasConceptScore W3147963921C530470458 @default.
• W3147963921 hasConceptScore W3147963921C54355233 @default.
• W3147963921 hasConceptScore W3147963921C55493867 @default.
• W3147963921 hasConceptScore W3147963921C71924100 @default.
• W3147963921 hasConceptScore W3147963921C81885089 @default.
• W3147963921 hasConceptScore W3147963921C86803240 @default.
• W3147963921 hasFunder F4320322795 @default.
• W3147963921 hasIssue "4" @default.
• W3147963921 hasLocation W31479639211 @default.
• W3147963921 hasLocation W31479639212 @default.
• W3147963921 hasOpenAccess W3147963921 @default.
• W3147963921 hasPrimaryLocation W31479639211 @default.
• W3147963921 hasRelatedWork W2024344351 @default.
• W3147963921 hasRelatedWork W2346343701 @default.

• next